Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Asterixis induced by carbamazepine therapy.

Rittmannsberger H, Leblhuber F.

Biol Psychiatry. 1992 Aug 15;32(4):364-8.

PMID:
1420650
2.

Asterixis induced by psychotropic drug treatment.

Rittmannsberger H.

Clin Neuropharmacol. 1996 Aug;19(4):349-55.

PMID:
8828998
3.

Asterixis as a side effect of carbamazepine therapy.

Rittmannsberger H, Leblhuber F, Sommer R.

Klin Wochenschr. 1991 Apr 4;69(6):279-81.

PMID:
1674759
4.

The treatment of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination.

Kishimoto A.

Prog Neuropsychopharmacol Biol Psychiatry. 1992 Jul;16(4):483-93.

PMID:
1641493
5.

Hyperammonemia in asterixis induced by carbamazepine: two case reports.

Ambrosetto G, Riva R, Baruzzi A.

Acta Neurol Scand. 1984 Mar;69(3):186-9.

PMID:
6720252
6.

Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study.

Okuma T, Yamashita I, Takahashi R, Itoh H, Otsuki S, Watanabe S, Sarai K, Hazama H, Inanaga K.

Pharmacopsychiatry. 1990 May;23(3):143-50.

PMID:
1973844
7.
8.

[Carbamazepine-fluvoxamine interaction. Consequences for the carbamazepine plasma level].

Cottencin O, Regnaut N, Thévenon-Gignac C, Thomas P, Goudemand M, Debruille C, Robert H.

Encephale. 1995 Mar-Apr;21(2):141-5. French.

PMID:
7781585
9.

Extrapyramidal syndrome related to lithium-carbamazepine combination therapy at therapeutic serum levels.

Palma JA, Fernandez-Torron R, Gallego Perez-Larraya J.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):102-3. doi: 10.1097/WNF.0b013e3181cbf83f.

PMID:
20375657
10.

Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect.

Brewerton TD.

Biol Psychiatry. 1986 Jun;21(7):677-85. No abstract available.

PMID:
3708039
11.

Rational polypharmacy in the bipolar affective disorders.

Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.

Epilepsy Res Suppl. 1996;11:153-80. Review.

PMID:
9294735
12.

Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.

Möller HJ, Kissling W, Riehl T, Bäuml J, Binz U, Wendt G.

Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(1-2):127-36.

PMID:
2664882
13.

The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.

Zhang ZJ, Kang WH, Li Q, Tan QR.

J Psychiatr Res. 2007 Nov;41(10):828-36. Epub 2006 Sep 29.

PMID:
17010995
14.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
15.

Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy.

Ginsberg LD.

Ann Clin Psychiatry. 2006;18 Suppl 1:19-22.

PMID:
16754408
16.
17.

Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.

Klein E, Bental E, Lerer B, Belmaker RH.

Arch Gen Psychiatry. 1984 Feb;41(2):165-70.

PMID:
6365015
18.

Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness.

Shukla S, Cook BL, Miller MG.

J Affect Disord. 1985 Nov;9(3):219-22.

PMID:
2867109
19.

The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.

Fawcett J, Kravitz HM.

J Clin Psychiatry. 1985 Feb;46(2):58-60.

PMID:
3968046
20.

Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.

Tohen M, Castillo J, Pope HG Jr, Herbstein J.

J Clin Psychopharmacol. 1994 Feb;14(1):67-70.

PMID:
8151006
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk